200 related articles for article (PubMed ID: 32486222)
1. Antibody Neutralization of an Influenza Virus that Uses Neuraminidase for Receptor Binding.
Gentles LE; Wan H; Eichelberger MC; Bloom JD
Viruses; 2020 May; 12(6):. PubMed ID: 32486222
[TBL] [Abstract][Full Text] [Related]
2. Mutations in Influenza A Virus Neuraminidase and Hemagglutinin Confer Resistance against a Broadly Neutralizing Hemagglutinin Stem Antibody.
Prachanronarong KL; Canale AS; Liu P; Somasundaran M; Hou S; Poh YP; Han T; Zhu Q; Renzette N; Zeldovich KB; Kowalik TF; Kurt-Yilmaz N; Jensen JD; Bolon DNA; Marasco WA; Finberg RW; Schiffer CA; Wang JP
J Virol; 2019 Jan; 93(2):. PubMed ID: 30381484
[TBL] [Abstract][Full Text] [Related]
3. Influenza viruses with receptor-binding N1 neuraminidases occur sporadically in several lineages and show no attenuation in cell culture or mice.
Hooper KA; Crowe JE; Bloom JD
J Virol; 2015 Apr; 89(7):3737-45. PubMed ID: 25609803
[TBL] [Abstract][Full Text] [Related]
4. A mutant influenza virus that uses an N1 neuraminidase as the receptor-binding protein.
Hooper KA; Bloom JD
J Virol; 2013 Dec; 87(23):12531-40. PubMed ID: 24027333
[TBL] [Abstract][Full Text] [Related]
5. Hemagglutinin Stalk-Reactive Antibodies Interfere with Influenza Virus Neuraminidase Activity by Steric Hindrance.
Chen YQ; Lan LY; Huang M; Henry C; Wilson PC
J Virol; 2019 Feb; 93(4):. PubMed ID: 30518651
[TBL] [Abstract][Full Text] [Related]
6. Extending the Stalk Enhances Immunogenicity of the Influenza Virus Neuraminidase.
Broecker F; Zheng A; Suntronwong N; Sun W; Bailey MJ; Krammer F; Palese P
J Virol; 2019 Sep; 93(18):. PubMed ID: 31375573
[TBL] [Abstract][Full Text] [Related]
7. Sera from Individuals with Narrowly Focused Influenza Virus Antibodies Rapidly Select Viral Escape Mutations
Davis AKF; McCormick K; Gumina ME; Petrie JG; Martin ET; Xue KS; Bloom JD; Monto AS; Bushman FD; Hensley SE
J Virol; 2018 Oct; 92(19):. PubMed ID: 30045982
[TBL] [Abstract][Full Text] [Related]
8. Neuraminidase-Inhibiting Antibody Titers Correlate with Protection from Heterologous Influenza Virus Strains of the Same Neuraminidase Subtype.
Walz L; Kays SK; Zimmer G; von Messling V
J Virol; 2018 Sep; 92(17):. PubMed ID: 29925654
[TBL] [Abstract][Full Text] [Related]
9. Role of Neuraminidase in Influenza A(H7N9) Virus Receptor Binding.
Benton DJ; Wharton SA; Martin SR; McCauley JW
J Virol; 2017 Jun; 91(11):. PubMed ID: 28356530
[TBL] [Abstract][Full Text] [Related]
10. Dissection of Epitope-Specific Mechanisms of Neutralization of Influenza Virus by Intact IgG and Fab Fragments.
Williams JA; Gui L; Hom N; Mileant A; Lee KK
J Virol; 2018 Mar; 92(6):. PubMed ID: 29263254
[TBL] [Abstract][Full Text] [Related]
11. Potential Role of Nonneutralizing IgA Antibodies in Cross-Protective Immunity against Influenza A Viruses of Multiple Hemagglutinin Subtypes.
Okuya K; Yoshida R; Manzoor R; Saito S; Suzuki T; Sasaki M; Saito T; Kida Y; Mori-Kajihara A; Kondoh T; Sato M; Kajihara M; Miyamoto H; Ichii O; Higashi H; Takada A
J Virol; 2020 Jun; 94(12):. PubMed ID: 32269119
[TBL] [Abstract][Full Text] [Related]
12. Antigenic Fingerprinting of Antibody Response in Humans following Exposure to Highly Pathogenic H7N7 Avian Influenza Virus: Evidence for Anti-PA-X Antibodies.
Khurana S; Chung KY; Coyle EM; Meijer A; Golding H
J Virol; 2016 Oct; 90(20):9383-93. PubMed ID: 27512055
[TBL] [Abstract][Full Text] [Related]
13. Serum strain-specific or cross-reactive neuraminidase inhibiting antibodies against pandemic А/California/07/2009(H1N1) influenza in healthy volunteers.
Desheva YA; Smolonogina TA; Donina SA; Rudenko LG
BMC Res Notes; 2015 Apr; 8():136. PubMed ID: 25889924
[TBL] [Abstract][Full Text] [Related]
14. Antigenic Drift of the Influenza A(H1N1)pdm09 Virus Neuraminidase Results in Reduced Effectiveness of A/California/7/2009 (H1N1pdm09)-Specific Antibodies.
Gao J; Couzens L; Burke DF; Wan H; Wilson P; Memoli MJ; Xu X; Harvey R; Wrammert J; Ahmed R; Taubenberger JK; Smith DJ; Fouchier RAM; Eichelberger MC
mBio; 2019 Apr; 10(2):. PubMed ID: 30967460
[TBL] [Abstract][Full Text] [Related]
15. Comparative Efficacy of Monoclonal Antibodies That Bind to Different Epitopes of the 2009 Pandemic H1N1 Influenza Virus Neuraminidase.
Jiang L; Fantoni G; Couzens L; Gao J; Plant E; Ye Z; Eichelberger MC; Wan H
J Virol; 2016 Jan; 90(1):117-28. PubMed ID: 26468531
[TBL] [Abstract][Full Text] [Related]
16. Novel Epitopes of the Influenza Virus N1 Neuraminidase Targeted by Human Monoclonal Antibodies.
Kirkpatrick Roubidoux E; Sano K; McMahon M; Carreño JM; Capuano C; Jiang K; Simon V; van Bakel H; Wilson P; Krammer F
J Virol; 2022 May; 96(9):e0033222. PubMed ID: 35446141
[TBL] [Abstract][Full Text] [Related]
17. Inactivated H7 Influenza Virus Vaccines Protect Mice despite Inducing Only Low Levels of Neutralizing Antibodies.
Kamal RP; Blanchfield K; Belser JA; Music N; Tzeng WP; Holiday C; Burroughs A; Sun X; Maines TR; Levine MZ; York IA
J Virol; 2017 Oct; 91(20):. PubMed ID: 28768855
[TBL] [Abstract][Full Text] [Related]
18. Vaccination with Recombinant Parainfluenza Virus 5 Expressing Neuraminidase Protects against Homologous and Heterologous Influenza Virus Challenge.
Mooney AJ; Gabbard JD; Li Z; Dlugolenski DA; Johnson SK; Tripp RA; He B; Tompkins SM
J Virol; 2017 Dec; 91(23):. PubMed ID: 28931689
[TBL] [Abstract][Full Text] [Related]
19. Characterization of antibodies specific for hemagglutinin and neuraminidase proteins of the 1918 and 2009 pandemic H1N1 viruses.
Liu Y; Liu X; Fang J; Shen X; Chen W; Lin X; Li H; Tan W; Wang Y; Zhao P; Qi Z
Vaccine; 2010 Dec; 29(2):183-90. PubMed ID: 21055499
[TBL] [Abstract][Full Text] [Related]
20. Antibodies Directed toward Neuraminidase N1 Control Disease in a Mouse Model of Influenza.
Job ER; Schotsaert M; Ibañez LI; Smet A; Ysenbaert T; Roose K; Dai M; de Haan CAM; Kleanthous H; Vogel TU; Saelens X
J Virol; 2018 Feb; 92(4):. PubMed ID: 29167342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
